Report - Biologic License Application STN BL 125075/0: Efalizumab for the Treatment of Chronic Plaque Psoriasis Dermatologic and Ophthalmic Drugs Advisory Committee.

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form